PROFESSIONAL EDITION

The largest community of pharma leaders

Endospan Enrolls First Patient in the TRIOMPHE IDE Study

HERZLIA, Israel–(BUSINESS WIRE)– #NEXUSaorta–Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, announces the first implant of the NEXUS™ Aortic Arch Stent Graft System on a patient with a thoracic aortic aneurysm as part of the TRIOMPHE Study in Norfolk, Virginia, January 11, 2021. The TRIOMPHE Study is a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS™ in treating thoracic aortic lesions involving the ao
Source Read More

Recent Articles